Heat shock proteins in long-lived worms and mice with insulin/insulin-Like


































Heat shock proteins (HSPs) have gained prominence in 
aging research and are thought to be of importance for 
both longevity and overall maintenance of proteome 
integrity with advancing age. The most compelling 
evidence so far has been collected from invertebrate 
models, in which it was found that longevity and 
thermotolerance were joint effects of certain mutations 
[1, 2], and that brief exposure to mild heat stress at a 
young age increased both HSP expression and 
organismic lifespan [3]. These investigations prompted 
studies of specific HSPs and their effects, and it was 
soon discovered, in D. melanogaster, that the hormesis 
effect of mild heat shock on survival was enhanced 
within transgenic strains carrying extra copies of the 
Hsp70 gene [4]. These results served to spark a broader 
interest in HSPs and their possible role in aging 
pathology, and it was soon found that systemic and 
lifelong overexpression of HSP-encoding genes could 
increase lifespan in Drosophila [5 - 8], as well as C. 
elegans [9 - 11]. The relevance of these observations  to  
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basic aging research was reinforced by the finding that 
loss of insulin / insulin-like signaling (IIS), the most 
robust pro-longevity genetic manipulation currently 
known, partly influenced longevity by modulating HSP 
expression, particularly the low molecular weight small 
HSPs [10, 12, 13]. Most notably, Hsu et al. [12] showed 
that expression of hsp-16.1,  hsp-16.49,  hsp-12.6 and 
sip-1 were all elevated in daf-2 mutant worms, and that 
expression of each HSP was required for the full effect 
of daf-2 on lifespan. Taken together, these observations, 
appeared consistent with a "chaperone overload" theory 
of aging [14], which proposed that HSP activity was 
critical for maintenance of proteostasis, such that 
increased HSP abundance could indeed contribute to 
lengthened lifespan and reduction of age-related disease 
[15].  
 
While efforts to increase invertebrate lifespan by 
augmenting HSP abundance have often been successful, 
it has not been demonstrated that systemic and lifelong 
 
 
www.impactaging.com                    573                                           AGING, June 2009, Vol.1 No.6HSP overexpression can extend mammalian lifespan. 
However, the overexpression of certain HSPs can 
ameliorate specific types of age-related pathology in 
laboratory rodents, including decline in muscle function 
[16], accumulation of toxic tau aggregates in neural 
tissue [17], development of insulin resistance [18], 
oxidative stress damage [19], and activation of 
inflammatory pathways [20], suggesting that results 
from invertebrate studies can indeed provide a useful 
guide for exploring the involvement of HSPs in 
vertebrate aging, and possibly, longevity. In bridging 
the gap between invertebrate and vertebrate models, the 
regulation of HSP expression by IIS provides a good 
starting point, given that the IIS pathway has effects on 
lifespan and a broad spectrum of age-related diseases 
that are in fact conserved across species [21]. In the C. 
elegans model, loss of IIS increases expression of small 
HSPs [12, 22], as well as HSPs of larger size [23, 24], 
possibly by enhancing binding of both daf-16 (FOXO) 
and HSF to promoter regions of HSP-encoding genes 
[12]. Each of these molecular components has 
orthologous elements in mice, although the mammalian 
system also differs in some key respects. In particular, 
circulating IGF-I levels in mice are linked to GH, such 
that both hormones are considered part of the same GH 
/ IGF-I endocrine axis. Despite this difference, however, 
loss of GH / IGF-I signaling in mice has effects on 
lifespan that parallel loss of IIS in C. elegans and 
Drosophila, as exemplified by a series of long-lived 
dwarf mouse models, including the GH-deficient 
Pit1(dw/dw) ("Snell") and Prop1(df/df) ("Ames") mice, 
the GH-insensitive Ghr(-/-) mice, and the PappA(-/-) 
mouse with localized reductions in IGF-I signaling [25]. 
It is therefore intriguing to ask whether such mutant 
mice, like the C. elegans daf-2 mutants, have elevated 
HSP expression levels, and whether such HSP 
expression patterns contribute to their aging-related 
phenotypes, as well as to their stress resistance 
properties [26]. 
 
Regulation of HSP expression by endocrine signals 
in long-lived mice 
 
The chaperone activity of HSPs is critical for recovery 
from stress and cellular insults, but HSPs have diverse 
functions that are of importance even in the absence of 
an external stress condition, including cellular transport, 
peptide synthesis and modulation of key cell signaling 
pathways [20, 27]. It is hardly surprising, in this sense, 
that systemic mechanisms would have evolved to 
enable precise control of the abundance and distribution 
of HSPs across major organ systems, and that this 
control might be accomplished through a circulating 
neuroendocrine factor. With these expectations in mind, 
and in view of the known effects of IIS on HSP 
expression in C. elegans, Swindell et al. [28] have 
recently examined the effects of the Pit1(dw/dw) and 
Ghr(-/-) mutations on HSP expression patterns in six 
different tissue types in the laboratory mouse (liver, 
kidney, heart, lung, muscle and neocortex). These 
mutations were of interest, since both lead to reduced 
IGF-I levels in circulation, as well as increased lifespan, 
presumably through mechanisms that would parallel 
those associated with the C. elegans daf-2 mutation. 
Surprisingly, however, effects of these mutations on 
gene expression varied among HSP-encoding genes, 
among tissue types, and with little unifying pattern. 
Rather than having widely elevated HSP expression 
levels, long-lived dwarf mice were instead a mosaic of 
both elevated and depressed HSP mRNAs, depending 
upon the tissue examined and the particular HSP target 
evaluated [28]. The specific role of GH / IGF-I in these 
expression patterns was evaluated by comparisons 
between  Pit1(dw/dw) and Ghr(-/-) mutants, and in 
general, it was only the declines of HSP expression 
resulting from Pit1(dw/dw) that were also shared by 
Ghr(-/-), particularly in liver and kidney. Unexpectedly, 
therefore, these results suggested that expression of 
some HSPs was positively related to GH / IGF-I signals, 
and this notion was further supported by the observation 
that a six-week treatment of GH injections increased 
hepatic expression of Hsph1 ( Hsp110),  Hspa5 ( Bip), 
Dnajb11 and Dnajc3 ( p58IPK) in the GH-deficient 
Ames dwarf mouse [28]. The picture that has emerged 
from these studies, therefore, is one of complex HSP 
regulation in vivo, with GH / IGF-I either indirectly or 
directly acting to modulate the expression of at least 
some HSP-encoding genes, but no generalized or 
systemic induction of HSP expression in long-lived 
dwarf mice. 
 
Should we conclude that the C. elegans system provides 
a poor mammalian analogue for investigating the 
contributions of HSPs to age-related pathology, and that 
alterations in HSP expression contribute to increased 
survivorship of daf-2 mutants in a fashion that is 
unparalleled in long-lived dwarf mice? Certainly not. 
Above all else, it is clear that, in mice, broad and 
general conclusions regarding the interaction between 
HSPs and longevity mutations are apt to be hazardous. 
This reflects, in part, the fact that there is considerable 
diversity among HSPs, both in terms of function and 
their regulation, such that only subsets of certain HSPs 
are likely to be co-regulated in vivo. On balance, there 
appears to be a stronger tendency for loss of GH / IGF-I 
signaling to decrease HSP expression in mice, rather 
than to increase it, but some patterns are in line with the 
C. elegans model. For instance, the alpha-crystallin 
HSP  Cryab, which is orthologous to the C. elegans 
Hsp-16 small HSPs [29], is increased by Pit1(dw/dw) in 
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and  Hspb8) were increased by both Pit1(dw/dw) and 
Ghr(-/-) in lung [28]. Another important consideration 
is that, in daf-2 mutants, differences in HSP expression 
between mutant and wild-type worms are amplified by 
an external stress condition [12, 22], suggesting the 
involvement of stress-activated regulatory factors, such 
as heat shock factor (HSF). It is indeed possible that, in 
long-lived dwarf mice, although basal HSP expression 
is generally lower, this is perhaps associated with a 
more robust heat shock response, such that under a 
stress condition, loss of GH / IGF-I signals would serve 
to augment HSP expression [30]. While intriguing, this 
idea has not, so far, been supported by investigations of 
HSP stress-response patterns in fibroblast cells from 
long-lived Pit1(dw/dw) mice [28, 31]. 
 
We can be assured that further work will reveal more 
impressive similarities, and differences, between the 
influence of mouse and C. elegans IIS longevity 
mutations on HSPs, both in terms of HSP function and 
transcriptional regulation. Interestingly, for example, it 
was recently found that mutant C. elegans worms 
lacking the AFD sensory neuron exhibited an altered 
heat shock response in somatic cells, even though such 
cells were not directly innervated by this sensory neuron 
[32]. In worms, therefore, machinery regulating HSP 
expression is partly under neuronal control, and it 
appears that a type of neuroendocrine signal mediates 
between sensory neurons and somatic cells to allow 
control of HSP expression under stress [32]. It will be 
of much interest to determine whether there exists 
parallelism between such, as yet unidentified, 
neuroendocrine signals in C. elegans, and the regulation 
of HSP expression by GH / IGF-I signals in mice. At 
the same time, it will be illuminating to develop and 
clarify a model by which HSP expression is regulated 
by GH / IGF-I signals in mice. For instance, it is 
necessary to understand whether GH / IGF-I signals are 
a direct modulator of HSP expression, and if not, which 
intermediate pathways act as secondary signals. It is 
indeed possible that effects of GH / IGF-I signals on in 
vivo HSP expression are very indirect, and mediated by 
metabolic responses to circulating GH / IGF-I (e.g. 
increased muscle mass, improved insulin sensitivity). It 
will also be important to evaluate whether effects of GH 
/ IGF-I on HSP expression are dependent upon HSF-1, 
although at present, the complex shifts in HSP 
expression documented in GH / IGF-I mutants suggest 
that a single transcription factor will not account for all 
modulation of HSP transcription. Lastly, given that GH 
/ IGF-I signals do modify HSP expression in mice, the 
possibility of complex feedback loops should be 
explored, by which HSP abundance might influence GH 
or IGF-I signals. Along these lines, transgenic mice 
overexpressing Hsp70 exhibit a growth deficit and a 
50% reduction in serum IGF-I levels [33], Hsp60 
augments IGF-I signals by inhibiting degradation of the 
IGF-I receptor in cardiac tissue [34], and in cartilage, 
Hsp90 appears to facilitate IGF-I-induced 
phosphorylation of AKT [35]. 
 
What's next? Can we "chaperone our way" to 
extended lifespan in mice?  
 
Establishing the contribution of HSPs to longevity in 
GH / IGF-I mutant mice, and whether this contribution 
parallels that described in daf-2 worms, will shed light 
on the more general issue of how HSPs might influence 
lifespan and age-related disease in mammalian systems. 
Clearly, HSP overexpression has, in many but not all 
cases, been successful as a pro-longevity manipulation 
in invertebrate models, presumably due to enhanced 
proteostasis with age and/or protection against oxidative 
stress damage [15]. It would, at present, be valuable to 
obtain a comparable success story involving laboratory 
rodents, which would establish that chaperones can be 
used as a pro-longevity therapeutic in mammals. 
Systemic and lifelong HSP overexpression (or elevated 
HSF-1 activity) seems unlikely to be a winning strategy, 
since there is now considerable evidence that this can 
increase mortality in organisms for which cancer figures 
prominently in the disease spectrum [33, 36 - 38]. 
Moreover, if we are to learn from the two manipulations 
most reliably known to increase mouse lifespan, loss of 
GH / IGF-I signals and dietary restriction, we'd walk 
away the notion that, at a systemic level, decreased 
expression of certain HSP-encoding genes (e.g., Hsph1) 
is associated with longevity more so than increased HSP 
expression [28, 39]. In consideration of this, it appears 
that modification of existing thought paradigms will be 
required for exploring the role of HSPs as longevity 
therapeutics, perhaps in combination with more 
nuanced genetic or pharmacological approaches. In 
some mitotic tissues, inhibition of HSF-1 activity or 
decreased HSP abundance may serve to combat 
malignant transformation [37]. On the other hand, this 
may be deleterious in tissues with post-mitotic cell 
populations, such as heart and the central nervous 
system [40, 41], where results generated from 
invertebrate models are more likely to be applicable in 
direct fashion, such that manipulations augmenting HSP 
activity might positively affect lifespan or certain 
disease outcomes. A good exemplar of this approach is 
the study of Li and Ren [42], in which cardiac-specific 
overexpression of IGF-I led to a small but significant 
increase in mouse lifespan, even though the anti-
apoptotic effects of this manipulation would likely have 
limited organismic survival if it were applied 
systemically or to other organ systems. Similar tissue-
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whether enhanced HSP abundance is a viable pro-
longevity strategy in mice, and indeed, cardiac tissue 
may provide a suitable domain for future investigations 
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